Alkermes's Aristada gets FDA approval to treat schizophrenia

Ireland-based Alkermes has received approval from the US Food and Drug Administration (FDA) for Aristada (aripiprazole lauroxil) extended-release injectable suspension to treat schizophrenia.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news